Risk Of Developing Liver Cancer After HCV Treatment

▼
Showing posts with label HCV generics. Show all posts
Showing posts with label HCV generics. Show all posts
Monday, February 4, 2019

Gilead's hepatitis C generics are on their way, but Epclusa's getting TV ads anyway

›
Gilead's hepatitis C generics are on their way, but Epclusa's getting TV ads anyway  by Beth Snyder Bulik | Feb 4, 2019  Gilea...
Saturday, February 2, 2019

Hepatitis C - Generic DAAs achieve excellent cure rates in Egypt

›
Source: infohep Treatment Outcomes Generic DAAs achieve excellent cure rates in Egypt matching those of branded drugs at a fraction of th...
Thursday, November 8, 2018

Drug pricing: still a barrier to elimination of HCV

›
The Lancet Gastroenterology & Hepatology Published: December, 2018 DOI: https://doi.org/10.1016/S2468-1253(18)30354-6 Drug pricing...
Saturday, November 3, 2018

Hepatitis Weekly Review & November Newsletters

›
Welcome, thanks for stopping by! Check out this month's index of exceptional Hepatitis Newsletters , and well written blogs; many p...
Monday, October 29, 2018

Gilead $1,100 a day drug. Now it will launch a generic at quarter the price

›
Gilead charged $1,100 a day for this drug. Now it will launch a generic at quarter the price By Ron Leuty – Reporter, San Francisco Busine...
Wednesday, October 10, 2018

Pathways to ensure universal and affordable access to hepatitis C treatment

›
In Case You Missed It Pathways to ensure universal and affordable access to hepatitis C treatment  Caitlin H. Douglass, Alisa Pedrana,...
Thursday, September 27, 2018

Gilead Subsidiary to Launch Authorized Generics of Epclusa® (Sofosbuvir/Velpatasvir) and Harvoni® (Ledipasvir/Sofosbuvir) for the Treatment of Chronic Hepatitis C

›
Of Interest October 29, 2018 Gilead $1,100 a day drug. Now it will launch a generic at quarter the price Sep 27, 2018 An ‘unusual decisi...
Thursday, September 20, 2018

Cost-effectiveness analysis of treatment timing considering the future entry of lower-cost generics for hepatitis C

›
In The News Monday, September 24, 2018 Gilead Subsidiary to Launch Authorized Generics of Epclusa® (Sofosbuvir/Velpatasvir) and Harvoni® ...
Wednesday, September 12, 2018

Greg Jefferys: Purchasing Hep C Generics

›
Update - In The News Monday, September 24, 2018 Gilead Subsidiary to Launch Authorized Generics of Epclusa® (Sofosbuvir/Velpatasvir) and ...
Wednesday, August 8, 2018

Hep C and B August Newsletters - Liver Wellness Tips & Generic Direct Acting Antivirals

›
News updated Aug 8, 2018 August Newsletters Welcome folks! Read the latest hep B or C news in this months collection of newsletters, ...
Wednesday, May 23, 2018

Drugmakers Blamed For Blocking Generics Have Jacked Up Prices And Cost U.S. Billions

›
Drugmakers Blamed For Blocking Generics Have Jacked Up Prices And Cost U.S. Billions May 23, 2018 Sydney Lupkin, Kaiser Health News Makers o...
Wednesday, March 7, 2018

Generic Hepatitis C Drugs Begin to Emerge

›
Recommended Reading Efficacy of Generic Oral Directly Acting Agents in Patients with Hepatitis C Virus Infection. J Viral Hepat. 2018 J...
1 comment: